Abstract
Rare hematopoietic stem cells (HSCs) can self-renew, establish the entire blood system and represent the basis of regenerative medicine applied to hematological disorders. Clinical use of HSCs is however limited by their inefficient expansion ex vivo, creating a need to further understand HSC expansion in vivo. After embryonic HSCs are born from the hemogenic endothelium, they migrate to the embryonic/fetal niche, where the future adult HSC pool is established by considerable expansion. This takes place at different anatomical sites and is controlled by numerous signals. HSCs then migrate to their adult niche, where they are maintained throughout adulthood. Exactly how HSC expansion is controlled during embryogenesis remains to be characterized and is an important step to improve the therapeutic use of HSCs. We will review the current knowledge of HSC expansion in the different fetal niches across several model organisms and highlight possible clinical applications.
Original language | English |
---|---|
Article number | 34 |
Number of pages | 11 |
Journal | Frontiers in cell and developmental biology |
Volume | 7 |
Issue number | MAR |
DOIs | |
Publication status | Published - 12 Mar 2019 |
Bibliographical note
Publisher Copyright:© 2019 Mahony and Bertrand.
Keywords
- zebrafish
- mammals
- CHT
- fetal liver
- hematopoietic (stem) cells
- caudal hematopoietic tissue
- microenvironment
ASJC Scopus subject areas
- Developmental Biology
- Cell Biology